Observational studyJournal for immunotherapy of cancer2019

STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia.

Marjolaine Debant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.